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AIMS: Given the impact of vascular injuries and oedema on brain damage caused
during stroke, vascular protection represents a major medical need. We hypothesized
that angiopoietin-like 4 (ANGPTL4), a regulator of endothelial barrier integrity, might
exert a protective effect during ischaemic stroke. METHODS AND RESULTS: Using a
murine transient ischaemic stroke model, treatment with recombinant ANGPTL4 led
to significantly decreased infarct size and improved behaviour. Quantitative
characteristics of the vascular network (density and branchpoints) were preserved in
ANGPTL4-treated mice. Integrity of tight and adherens junctions was also quantified
and ANGPTL4-treated mice displayed increased VE-cadherin and claudin-5-positive
areas. Brain oedema was thus significantly decreased in ANGPTL4-treated mice. In
accordance, vascular damage and infarct severity were increased in angptl4-deficient
mice thus providing genetic evidence that ANGPTL4 preserves brain tissue from
ischaemia-induced alterations. Altogether, these data show that ANGPTL4 protects
not only the global vascular network, but also interendothelial junctions and controls
both deleterious inflammatory response and oedema. Mechanistically, ANGPTL4
counteracted VEGF signalling and thereby diminished Src-signalling downstream
from VEGFR2. This led to decreased VEGFR2-VE-cadherin complex disruption,
increased stability of junctions and thus increased endothelial cell barrier integrity of
the cerebral microcirculation. In addition, ANGPTL4 prevented neuronal loss in the
ischaemic area. CONCLUSION: These results, therefore, show ANGPTL4 counteracts
the loss of vascular integrity in ischaemic stroke, by restricting Src kinase signalling
downstream from VEGFR2. ANGPTL4 treatment thus reduces oedema, infarct size,
neuronal loss, and improves mice behaviour. These results suggest that ANGPTL4
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